The conference will address state-of-the-art basic and translational cancer research, focusing on recent discoveries in immunotherapy, genetic alterations, metabolism, microbiome, tumor microenvironment, senescence, cancer progression and metastases, and innovative technologies in cancer therapy. The program will include presentations by leading scientists and clinicians, and short talks selected from abstracts.